HOME >> MEDICINE >> NEWS
About 5 percent of adults with insomnia use alternative therapies

More than 1.6 million U.S. adults are estimated to use complementary and alternative therapies to treat insomnia or trouble sleeping, according to the results of a national survey published in the September 18 issue of Archives of Internal Medicine, a theme issue on sleep.

Approximately 10 to 34 percent of Americans regularly experience difficulty sleeping, also known as insomnia, according to background information in the article. Treatment options include prescription and non-prescription medications, antidepressants and cognitive behavioral therapy. Complementary and alternative medicine (CAM) therapies, defined as those practices that are not scientifically proven and are not currently considered part of conventional medicine, also are used to treat insomnia. Such therapies include herbal medicines and relaxation techniques.

Nancy J. Pearson, Ph.D., and colleagues at the National Center for Complementary and Alternative Medicine, National Institutes of Health, Bethesda, Md., analyzed data from a national survey of 31,044 adults conducted in 2002. Respondents answered one question about whether they regularly had insomnia or trouble sleeping in the past 12 months and completed a 10-minute supplemental survey on the use of 27 types of CAM therapies. The interview also included questions on over 50 other health conditions. Four items assessed behavior and motivation for using CAM therapies.

Of the adults interviewed, 17.4 percent reported that they regularly had insomnia or trouble sleeping in the past year. Difficulty sleeping was more common in women than men, most prevalent between ages 45 and 64, and was associated with obesity, hypertension, congestive heart failure and anxiety or depression, but not diabetes. Of those with insomnia or trouble sleeping, 4.5 percent reported that they had used CAM to treat the condition, which is equal to about 1.62 million adults in the general population. Survey respondents who were you
'"/>

Contact: National Center for Complementary and Alternative Medicine
301-496-7790
JAMA and Archives Journals
18-Sep-2006


Page: 1 2

Related medicine news :

1. Nothing About Us Without Us
2. Premature babies and SIDS: Doctors should make special effort to talk to parents About Risk
3. About 70 percent of older adults use alternative medicine
4. Stomach cancer rate set to fall further 25 percent over next decade
5. Sleep apnea increases risk of heart attack or death by 30 percent
6. Childhood immunization against pneumonia cuts hospital admissions by almost 40 percent
7. Hospital errors rise 3 percent -- HealthGrades patient-safety study
8. Chronic pain up almost 40 percent among US workers in past decade
9. Annual study finds top hospitals have 28 percent lower mortality rate
10. 100 percent juices found as beneficial to health as fruits and vegetables
11. UGA study finds that caffeine cuts post-workout pain by nearly 50 percent

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: About percent adults with insomnia use alternative therapies

(Date:5/19/2013)... Atlanta, GA (PRWEB) May 19, 2013 The ... and 2pm at the Columbus Georgia Convention & Trade Center ... are invited to attend. AMTC auditions are free of charge. ... the starting point for hundreds of successful artists and grads ... new face for European Tombolini , Chris Young - on ...
(Date:5/19/2013)... The Da Vinci robot lawyers at Wright & ... first trial involving a Da Vinci surgical robot lawsuit. ... was filed by the widow of a man who ... robot-assisted prostate removal, according to a report from Bloomberg ... alleges those complication’s hastened his death. (Estate of ...
(Date:5/18/2013)... The American Society for Gastrointestinal Endoscopy (ASGE) will honor ... ninth annual ASGE Crystal Awards on Sunday, May 19, ... year,s event will begin at ... Held in conjunction with Digestive Disease Week (DDW), the ... and scientific pursuit. The event will recognize the 2013 ...
(Date:5/18/2013)... Online watch retailer Time and Gems is offering ... at a fraction of its usual cost. With great deals ... buyers are urged to take advantage of Time and Gems’ ... from a brick-and-mortar store, buyers now have the option of ... unbelievable rates. Although some buyers may have qualms about buying ...
(Date:5/18/2013)... (HealthDay News) -- Just a few extra cups of ... an autoimmune liver disease known as primary sclerosing cholangitis ... Mayo Clinic in Rochester, Minn., found that drinking coffee ... disease, which can lead to cirrhosis of the liver, ... not prove a cause-and-effect relationship. "While rare, ...
Breaking Medicine News(10 mins):Health News:Actors, Models and Talent for Christ Hosting Auditions in Columbus, GA June 1st in Search of Local Talent 2Health News:Da Vinci Surgical Robot Lawyers at Wright & Schulte LLC Note Recent Developments in Da Vinci Robot Lawsuit Trial 2Health News:Da Vinci Surgical Robot Lawyers at Wright & Schulte LLC Note Recent Developments in Da Vinci Robot Lawsuit Trial 3Health News:Da Vinci Surgical Robot Lawyers at Wright & Schulte LLC Note Recent Developments in Da Vinci Robot Lawsuit Trial 4Health News:ASGE and ASGE foundation hold Crystal Awards dinner as part of Digestive Disease Week®, May 19, in Orlando 2Health News:ASGE and ASGE foundation hold Crystal Awards dinner as part of Digestive Disease Week®, May 19, in Orlando 3Health News:ASGE and ASGE foundation hold Crystal Awards dinner as part of Digestive Disease Week®, May 19, in Orlando 4Health News:ASGE and ASGE foundation hold Crystal Awards dinner as part of Digestive Disease Week®, May 19, in Orlando 5Health News:ASGE and ASGE foundation hold Crystal Awards dinner as part of Digestive Disease Week®, May 19, in Orlando 6Health News:ASGE and ASGE foundation hold Crystal Awards dinner as part of Digestive Disease Week®, May 19, in Orlando 7Health News:Time and Gems Offers Buyers the Largest Collection of Rolex Watches Yet 2Health News:Time and Gems Offers Buyers the Largest Collection of Rolex Watches Yet 3Health News:Study Links Coffee to Lower Risk for Rare Liver Disease 2
(Date:5/17/2013)...  Sanofi (EURONEXT: SAN and NYSE: SNY ) ... , examining the selective JAK2 inhibitor SAR302503 for ... groups. The primary endpoint assessed the proportion of patients ... reported in previous trials, the most common adverse events ... be presented at an upcoming medical congress. ...
(Date:5/17/2013)...  Boston Scientific Corporation (NYSE: BSX ) ... Program May 21-24 in Paris . ... rich and diversified set of data this year at ... global chief medical officer, Boston Scientific.  "The primary endpoint ... NG PROMUS trial, which evaluated our Promus PREMIER ™ ...
(Date:5/16/2013)... , May 16, 2013  PTC Therapeutics, Inc., ... on Form S-1 with the U.S. Securities and Exchange ... of its common stock. The number of shares to ... have not been determined. (Logo:  http://photos.prnewswire.com/prnh/20010919/PTCLOGO ... are acting as joint book-running managers for the offering. ...
Breaking Medicine Technology:Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 2Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 3Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 4Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 5Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 6Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 2Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 3Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 4Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 5Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 6Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 7Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 8PTC Therapeutics, Inc. Files Registration Statement for Proposed Initial Public Offering 2
Cached News: